EP Biocomposites Limited (BOM:543595)
India · Delayed Price · Currency is INR 98.00
0.00 (0.00%)
At close: Feb 12, 2026
EP Biocomposites Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 116.76 | 120.06 | 114.39 | 71.31 | 80.6 | 29.48 |
| 116.76 | 120.06 | 114.39 | 71.31 | 80.6 | 29.48 | |
Revenue Growth (YoY) | 2.02% | 4.96% | 60.42% | -11.52% | 173.39% | -13.54% |
Cost of Revenue | 76.37 | 77.48 | 75.25 | 41.22 | 49.76 | 18.18 |
Gross Profit | 40.39 | 42.59 | 39.15 | 30.09 | 30.84 | 11.3 |
Selling, General & Admin | 18.34 | 18.68 | 19.1 | 15.95 | 12.96 | 4.72 |
Other Operating Expenses | 5.66 | 5.34 | 3.72 | 3.42 | 4.05 | 1.98 |
Operating Expenses | 25.04 | 25.14 | 23.82 | 20.36 | 17.67 | 6.71 |
Operating Income | 15.35 | 17.45 | 15.33 | 9.72 | 13.17 | 4.6 |
Interest Expense | -3.35 | -3.55 | -0.35 | -2.03 | -1.56 | - |
Interest & Investment Income | 0.28 | 0.28 | 0.73 | 0.45 | 0.06 | 0.03 |
Other Non Operating Income (Expenses) | 0 | - | - | -0 | - | 0.02 |
EBT Excluding Unusual Items | 12.28 | 14.17 | 15.71 | 8.14 | 11.66 | 4.64 |
Gain (Loss) on Sale of Assets | -0 | -0 | - | - | - | - |
Pretax Income | 12.27 | 14.17 | 15.71 | 8.14 | 11.66 | 4.64 |
Income Tax Expense | 3.11 | 3.86 | 4.21 | 2.38 | 3.57 | 1.06 |
Net Income | 9.16 | 10.31 | 11.5 | 5.76 | 8.09 | 3.58 |
Net Income to Common | 9.16 | 10.31 | 11.5 | 5.76 | 8.09 | 3.58 |
Net Income Growth | -19.24% | -10.34% | 99.57% | -28.82% | 126.09% | 88.82% |
Shares Outstanding (Basic) | 2 | 2 | 2 | 1 | 1 | 0 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 1 | 1 | 0 |
Shares Change (YoY) | -0.59% | - | 15.13% | 71.17% | 127.55% | - |
EPS (Basic) | 5.46 | 6.13 | 6.84 | 3.94 | 9.49 | 9.55 |
EPS (Diluted) | 5.46 | 6.13 | 6.84 | 3.94 | 9.48 | 9.55 |
EPS Growth | -18.77% | -10.35% | 73.54% | -58.44% | -0.70% | - |
Free Cash Flow | -2.8 | -5.11 | -14.8 | -8.17 | -47.55 | 0.32 |
Free Cash Flow Per Share | -1.67 | -3.04 | -8.80 | -5.59 | -55.72 | 0.85 |
Gross Margin | 34.59% | 35.47% | 34.22% | 42.19% | 38.26% | 38.34% |
Operating Margin | 13.15% | 14.53% | 13.40% | 13.63% | 16.34% | 15.60% |
Profit Margin | 7.84% | 8.59% | 10.05% | 8.08% | 10.04% | 12.14% |
Free Cash Flow Margin | -2.39% | -4.26% | -12.94% | -11.45% | -58.99% | 1.08% |
EBITDA | 16.39 | 18.57 | 16.33 | 10.72 | 13.83 | 4.6 |
EBITDA Margin | 14.04% | 15.47% | 14.28% | 15.03% | 17.16% | 15.61% |
D&A For EBITDA | 1.04 | 1.13 | 1.01 | 1 | 0.66 | 0 |
EBIT | 15.35 | 17.45 | 15.33 | 9.72 | 13.17 | 4.6 |
EBIT Margin | 13.15% | 14.53% | 13.40% | 13.63% | 16.34% | 15.60% |
Effective Tax Rate | 25.38% | 27.26% | 26.79% | 29.22% | 30.58% | 22.88% |
Revenue as Reported | 118.11 | 121.15 | 117.38 | 72.97 | 80.76 | 29.52 |
Advertising Expenses | - | 0.29 | 0.29 | 0.19 | 0.11 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.